Our Research
Drug Discovery Engine
Active Research Programs
ALS Research Collaborative
ARC Data Commons
Our Labs
Publications
AQ Translational Research Center
About Us
ALS TDI: 25 Years
Our Team
ALS TDI FAQ
Schedule a Lab Tour
Contact Us
Our Financials
Take Action
Donate
Attend an Event
Browse Fundraisers
Get Updates
Join Our Study
Spread Awareness
Shop Our Store
What is ALS
ALS Treatments
Newly Diagnosed
Veterans with ALS
ALS FAQ
News & Resources
ALS Trial Navigator
News & Insights
Let Us Help
ALS Town Halls
Join Our Study
Find ALS Trials
Let Us Help
Sign In
Our Research
Drug Discovery Engine
Active Research Programs
The ARC Study
ARC Data Commons
Our Labs
Publications
AQ Translational Research Center
About Us
ALS TDI: 25 Years
Our Team
ALS TDI FAQ
Schedule a Lab Tour
Contact Us
Our Financials
Take Action
Donate
Attend an Event
Browse Fundraisers
Get Updates
Join Our Study
Spread Awareness
Shop Our Store
What is ALS
ALS Treatments
Newly Diagnosed
Veterans with ALS
ALS FAQ
News & Resources
ALS Trial Navigator
News and Insights
Let Us Help
ALS Town Halls
Shop Our Store
Search
Donate
Search
Donate
News & Resources
>
News and Insights
>
Article
A Message From Our Chief Scientific Officer Regarding COVID-19
April 21, 2020
Share
To the ALS Community,
Many of you have had questions about whether the ALS Therapy Development Institute (
ALS TDI
) science team will be able to continue our research amidst the COVID-19 pandemic.
I want to assure you that our team continues to work and remains as committed as ever to ending ALS, even during these challenging times.
These unprecedented circumstances have challenged us. Our scientists have had to develop new strategies to protect one another while continuing to move ALS research forward. I am extremely proud of the science team at ALS TDI for how well we have been able to adapt our work to safely continue our operations
.
In addition to having an amazing team, ALS TDI’s commitment to efficiency has made us uniquely poised to continue some of our most vital research at this time.
Efficiencies we already had in place, such as automation systems, robots, and a telemedicine-based clinical research program have all proven invaluable during this time. It is thanks to these efficiencies that we now have the ability to remotely continue critical projects like cell-based drug screens and the Precision Medicine Program (
PMP
).
In addition, there are various projects and experiments that our science team can still continue to execute while working from home and limiting the number of staff going into the lab. We continue to work.
We continue to communicate. We continue to learn. We will not be distracted from our mission
.
While we are slowed in some ways, the research that we are able to do, and the funding that we are able to bring in over these next few weeks, will go a long way in helping to maintain our momentum.
For those who are able, and would like to donate, please
donate today
to support ALS research at ALS TDI.
Thank you for your continued support. I wish you, your families, and friends good health and safety through this challenging time ahead.
We will get through it together.
Keep calm, carry on, while washing your hands, and staying safe at home.
Sincerely,
Fernando Vieira, M.D., CSO
The ALS Therapy Development Institute
Watch this video
from Fernando to learn more about how our science team is continuing ALS research right now.
Donate Now to Continue ALS Research
Subscribe
Sign up
to receive updates about the latest ALS research, ALS TDI's work, and the community.
Stay Informed
Related Reading
What Drives the 2025 ALS TDI TCS New York City Marathon Team
Read more
Strategic Choices, Maximum Impact: How ALS TDI Prioritizes Drug Discovery Projects
Read more
Attend the ALS TDI Summit on October 17th!
Read more
Follow Us
Learn more about our team, what we're working on in the lab, and our amazing community by following us on social media!
Author:
Fernando Vieira
Talk with Us
Whether you have questions about research, resources, clinical trials, or just want to connect and have a conversation,
we want to hear from you.
Let us help
Follow Us
Learn more about our team, what we're working on in the lab, and our amazing community by following us on social media!
Related Reading
What Drives the 2025 ALS TDI TCS New York City Marathon Team
Read more
Strategic Choices, Maximum Impact: How ALS TDI Prioritizes Drug Discovery Projects
Read more
Attend the ALS TDI Summit on October 17th!
Read more
Subscribe
Sign up
to receive updates about the latest ALS research, ALS TDI's work, and the community
Stay Informed
Share To
Can we help you?
Enter details below if you would like a member
of the ALS TDI team to contact you.
{{errorMessage}}
First Name
first name is required
too many characters entered
Last Name
last name is required
too many characters entered
Email
email is required
invalid email, this field should be in the format 'user@example.com'
invalid email, this field should be in the format 'user@example.com'
too many characters entered
Phone
phone is required
too many characters entered
State
Select a State
state is required
too many characters entered
Country
Select a Country
country is required
too many characters entered
How would you like to be contacted
Email
Phone
I am (relation to ALS)
Select a relation to ALS
relation to ALS is required
too many characters entered
Please specify
relation to als other is required
too many characters entered
I or a member of my family carry a genetic mutation related to ALS
Yes
No
please specify
Please provide additional details so that a
member of the ALS TDI team can assist you.
too many characters entered
Submit